FDA Approved: ZIRGAN — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA has approved a supplemental application for Zirgan (ganciclovir ophthalmic gel) submitted by Bausch & Lomb Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Keratitis

Drugs mentioned

• ZIRGAN (GANCICLOVIR)

Snippet

SUPPL AP for ZIRGAN (GANCICLOVIR)